Switching from efavirenz to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces central nervous system symptoms in people living with HIV
Lists
Only you see this
Abstract
The single-pill combination regimens E/C/F/TAF is safe and well tolerated. This study reveals that switching from EFV to E/C/F/TAF significantly reduces neuropsychiatric toxicity symptoms in people living with HIV with grade 2 or higher CNS complaints.
BibTeX
@inproceedings{xia2021switching,
author = {Huan Xia and Xiaojie Huang and Yue Hu and Liying Gao and Yue Wu and Hao Wu and Zhongfang Yan and Ping Ma},
title = {{Switching from efavirenz to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide reduces central nervous system symptoms in people living with HIV}},
booktitle = {Chinese},
year = {2021},
doi = {10.1097/cm9.0000000000001824},
}Loading related content...